IL161599A0 - Method for the treatment of over-active bladder - Google Patents
Method for the treatment of over-active bladderInfo
- Publication number
- IL161599A0 IL161599A0 IL16159902A IL16159902A IL161599A0 IL 161599 A0 IL161599 A0 IL 161599A0 IL 16159902 A IL16159902 A IL 16159902A IL 16159902 A IL16159902 A IL 16159902A IL 161599 A0 IL161599 A0 IL 161599A0
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- over
- active bladder
- bladder
- active
- Prior art date
Links
- 206010020853 Hypertonic bladder Diseases 0.000 title 1
- 208000009722 Overactive Urinary Bladder Diseases 0.000 title 1
- 208000020629 overactive bladder Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0103668A SE0103668D0 (sv) | 2001-11-02 | 2001-11-02 | Method for the treatment of overactive blader |
PCT/SE2002/001990 WO2003037341A1 (en) | 2001-11-02 | 2002-11-01 | Method for the treatment of overactive bladder |
Publications (1)
Publication Number | Publication Date |
---|---|
IL161599A0 true IL161599A0 (en) | 2004-09-27 |
Family
ID=20285870
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16159902A IL161599A0 (en) | 2001-11-02 | 2002-11-01 | Method for the treatment of over-active bladder |
Country Status (13)
Country | Link |
---|---|
US (1) | US20040248914A1 (xx) |
EP (1) | EP1450805A1 (xx) |
JP (1) | JP2005511561A (xx) |
KR (1) | KR20050042211A (xx) |
CN (1) | CN1622806A (xx) |
BR (1) | BR0213776A (xx) |
CA (1) | CA2465140A1 (xx) |
IL (1) | IL161599A0 (xx) |
MX (1) | MXPA04004071A (xx) |
NO (1) | NO20042139L (xx) |
SE (1) | SE0103668D0 (xx) |
WO (1) | WO2003037341A1 (xx) |
ZA (1) | ZA200403199B (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006121389A1 (en) * | 2005-05-10 | 2006-11-16 | Astrazeneca Ab | Use of a neurokinin-2 receptor antagonist for treating or preventing detrusor overactivity |
US10441620B2 (en) * | 2016-09-21 | 2019-10-15 | Wellstrong Biotech Co., Ltd. | Method for protection of bladder from damage |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1170417B (de) * | 1960-11-08 | 1964-05-21 | Recip Ab | Verfahren zur Herstellung eines Diphenyl-butylamins mit die Coronargefaesse erweiternder Wirkung |
US5382600A (en) * | 1988-01-22 | 1995-01-17 | Pharmacia Aktiebolag | 3,3-diphenylpropylamines and pharmaceutical compositions thereof |
GB8906166D0 (en) * | 1989-03-17 | 1989-05-04 | Pfizer Ltd | Therapeutic agents |
GB9310713D0 (en) * | 1993-05-24 | 1993-07-07 | Zeneca Ltd | Aryl substituted heterocycles |
GB9317104D0 (en) * | 1993-08-17 | 1993-09-29 | Zeneca Ltd | Therapeutic heterocycles |
US6008223A (en) * | 1994-10-27 | 1999-12-28 | Zeneca Limited | Therapeutic compounds |
GB9505084D0 (en) * | 1995-03-14 | 1995-05-03 | Pfizer Ltd | Benzamide derivative |
GB9922519D0 (en) * | 1998-10-07 | 1999-11-24 | Zeneca Ltd | Compounds |
GB9924141D0 (en) * | 1998-10-30 | 1999-12-15 | Zeneca Ltd | Treatment of gastric asthma |
GB9826941D0 (en) * | 1998-12-09 | 1999-02-03 | Zeneca Pharmaceuticals | Compounds |
GB0015246D0 (en) * | 2000-06-22 | 2000-08-16 | Astrazeneca Ab | Method for the treatment of urinary incontinence |
-
2001
- 2001-11-02 SE SE0103668A patent/SE0103668D0/xx unknown
-
2002
- 2002-11-01 EP EP02783903A patent/EP1450805A1/en not_active Withdrawn
- 2002-11-01 IL IL16159902A patent/IL161599A0/xx unknown
- 2002-11-01 US US10/494,387 patent/US20040248914A1/en not_active Abandoned
- 2002-11-01 KR KR1020047006519A patent/KR20050042211A/ko not_active Application Discontinuation
- 2002-11-01 MX MXPA04004071A patent/MXPA04004071A/es unknown
- 2002-11-01 CN CNA028266005A patent/CN1622806A/zh active Pending
- 2002-11-01 JP JP2003539684A patent/JP2005511561A/ja active Pending
- 2002-11-01 BR BR0213776-3A patent/BR0213776A/pt not_active IP Right Cessation
- 2002-11-01 CA CA002465140A patent/CA2465140A1/en not_active Abandoned
- 2002-11-01 WO PCT/SE2002/001990 patent/WO2003037341A1/en active Application Filing
-
2004
- 2004-04-28 ZA ZA200403199A patent/ZA200403199B/en unknown
- 2004-05-25 NO NO20042139A patent/NO20042139L/no unknown
Also Published As
Publication number | Publication date |
---|---|
JP2005511561A (ja) | 2005-04-28 |
SE0103668D0 (sv) | 2001-11-02 |
BR0213776A (pt) | 2004-11-09 |
ZA200403199B (en) | 2005-02-09 |
US20040248914A1 (en) | 2004-12-09 |
CN1622806A (zh) | 2005-06-01 |
CA2465140A1 (en) | 2003-05-08 |
EP1450805A1 (en) | 2004-09-01 |
WO2003037341A1 (en) | 2003-05-08 |
NO20042139L (no) | 2004-06-25 |
KR20050042211A (ko) | 2005-05-06 |
MXPA04004071A (es) | 2004-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1249850A1 (zh) | 治療多發性硬化症的方法 | |
GB0512560D0 (en) | Bioreactors for well treatment | |
IL159344A0 (en) | Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease | |
GB0118373D0 (en) | Novel therapeutic method | |
GB0129976D0 (en) | Treatment method | |
GB0120147D0 (en) | Treatment method | |
EP1389105A4 (en) | METHOD OF TREATMENT | |
GB0124124D0 (en) | Methods of treatment | |
IL155769A0 (en) | Method for the treatment of inflammation | |
GB0112216D0 (en) | Method of treatment | |
GB0118892D0 (en) | Method of treatment | |
GB0222082D0 (en) | Fluid treatment apparatus | |
GB0130763D0 (en) | Treatment methods | |
IL161599A0 (en) | Method for the treatment of over-active bladder | |
GB0104555D0 (en) | New Therapeutic method | |
EP1372630A4 (en) | AGENT FOR THE TREATMENT OF THE HYPERACTIVE BLADDER | |
GB0126253D0 (en) | Treatment method | |
GB2413798B (en) | Bioreactors for well treatment | |
AU2002367463A8 (en) | Novel p53bp2 compounds for therapy and diagnosis and methods for using same | |
GB0102927D0 (en) | Treatment method | |
GB0116029D0 (en) | Method of treatment | |
GB0125105D0 (en) | Method of treatment | |
GB0126094D0 (en) | Method of treatment | |
GB0111487D0 (en) | Method of treatment | |
GB0102559D0 (en) | Treatment for angiogenesis-dependant condition |